127 related articles for article (PubMed ID: 9873565)
1. H-phosphonate derivatives as novel peptide deformylase inhibitors.
Hu YJ; Rajagopalan PT; Pei D
Bioorg Med Chem Lett; 1998 Sep; 8(18):2479-82. PubMed ID: 9873565
[TBL] [Abstract][Full Text] [Related]
2. Identification of a potent peptide deformylase inhibitor from a rationally designed combinatorial library.
Wei Y; Yi T; Huntington KM; Chaudhury C; Pei D
J Comb Chem; 2000; 2(6):650-7. PubMed ID: 11126293
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of peptide deformylase inhibitors.
Huntington KM; Yi T; Wei Y; Pei D
Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
[TBL] [Abstract][Full Text] [Related]
4. Oxygen-mediated inactivation of peptide deformylase.
Rajagopalan PT; Pei D
J Biol Chem; 1998 Aug; 273(35):22305-10. PubMed ID: 9712848
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the design of antibiotics targeting peptide deformylase.
Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
Pratt LM; Beckett RP; Davies SJ; Launchbury SB; Miller A; Spavold ZM; Todd RS; Whittaker M
Bioorg Med Chem Lett; 2001 Oct; 11(19):2585-8. PubMed ID: 11551755
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of bacterial peptide deformylase by biaryl acid analogs.
Green BG; Toney JH; Kozarich JW; Grant SK
Arch Biochem Biophys; 2000 Mar; 375(2):355-8. PubMed ID: 10700392
[TBL] [Abstract][Full Text] [Related]
8. Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents.
Giglione C; Pierre M; Meinnel T
Mol Microbiol; 2000 Jun; 36(6):1197-205. PubMed ID: 10931273
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cobalt(II)-substituted peptide deformylase: function of the metal ion and the catalytic residue Glu-133.
Rajagopalan PT; Grimme S; Pei D
Biochemistry; 2000 Feb; 39(4):779-90. PubMed ID: 10651644
[TBL] [Abstract][Full Text] [Related]
10. Purification, characterization, and inhibition of peptide deformylase from Escherichia coli.
Rajagopalan PT; Datta A; Pei D
Biochemistry; 1997 Nov; 36(45):13910-8. PubMed ID: 9374870
[TBL] [Abstract][Full Text] [Related]
11. Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
Apfel C; Banner DW; Bur D; Dietz M; Hirata T; Hubschwerlen C; Locher H; Page MG; Pirson W; Rossé G; Specklin JL
J Med Chem; 2000 Jun; 43(12):2324-31. PubMed ID: 10882358
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a human peptide deformylase: implications for antibacterial drug design.
Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
[TBL] [Abstract][Full Text] [Related]
13. A direct spectrophotometric assay for peptide deformylase.
Guo XC; Ravi Rajagopalan PT; Pei D
Anal Biochem; 1999 Sep; 273(2):298-304. PubMed ID: 10469501
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding group.
Smith HK; Beckett RP; Clements JM; Doel S; East SP; Launchbury SB; Pratt LM; Spavold ZM; Thomas W; Todd RS; Whittaker M
Bioorg Med Chem Lett; 2002 Dec; 12(24):3595-9. PubMed ID: 12443784
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
[TBL] [Abstract][Full Text] [Related]
16. Determination of substrate specificity for peptide deformylase through the screening of a combinatorial peptide library.
Hu YJ; Wei Y; Zhou Y; Rajagopalan PT; Pei D
Biochemistry; 1999 Jan; 38(2):643-50. PubMed ID: 9888804
[TBL] [Abstract][Full Text] [Related]
17. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
[TBL] [Abstract][Full Text] [Related]
19. [Peptide-deformylase inhibitors, a new class of antibiotics].
Dubreuil L
Presse Med; 2002 Nov; 31(38):1810-2. PubMed ID: 12497724
[TBL] [Abstract][Full Text] [Related]
20. Peptide deformylase of eukaryotic protists: a target for new antiparasitic agents?
Meinnel T
Parasitol Today; 2000 Apr; 16(4):165-8. PubMed ID: 10725904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
